Obs Med: Hypertension — Pre-eclampsia vs Chronic Hypertension (MRCP Part 1)
- Crack Medicine
- 6 minutes ago
- 4 min read
TL;DR
For MRCP Part 1, differentiating pre-eclampsia from chronic hypertension is a common and high-yield obstetric medicine topic. Focus on timing of onset, proteinuria, maternal organ dysfunction, fetal complications, and safe antihypertensive prescribing in pregnancy. Questions frequently test the “20-week rule”, severe-feature recognition, and contraindicated drugs such as ACE inhibitors.
Why This Topic Matters in MRCP Part 1
The MRCP examination repeatedly assesses:
Recognition of hypertensive disorders in pregnancy
Safe prescribing during pregnancy
Maternal complications of severe disease
Fetal complications linked to placental insufficiency
Interpretation of laboratory findings
Many candidates lose marks because they fail to apply the timing of onset correctly or forget that modern definitions of pre-eclampsia do not always require significant proteinuria.
Core Definitions
Condition | Definition | Key Feature |
Chronic hypertension | Hypertension present before pregnancy or before 20 weeks’ gestation | Usually persists postpartum |
Gestational hypertension | New hypertension after 20 weeks without proteinuria | No end-organ dysfunction |
Pre-eclampsia | Hypertension after 20 weeks with proteinuria and/or maternal organ dysfunction | Placental disease |
Severe pre-eclampsia | Pre-eclampsia with severe hypertension or organ injury | Obstetric emergency |
HELLP syndrome | Haemolysis, Elevated Liver enzymes, Low Platelets | Severe pre-eclampsia variant |
The 5 Most Tested Subtopics
1. Timing of Onset
This is the single most important discriminator in exam questions.
Chronic hypertension
Present before conception, or
Diagnosed before 20 weeks’ gestation
Pre-eclampsia
Develops after 20 weeks
Typically occurs in the third trimester
Exam Pearl
A woman presenting with hypertension at 12 weeks is far more likely to have chronic hypertension than pre-eclampsia.
2. Proteinuria and Organ Dysfunction
Traditional teaching focused heavily on proteinuria, but MRCP increasingly tests updated diagnostic criteria.
Features suggesting pre-eclampsia
Proteinuria
Thrombocytopenia
Raised transaminases
Acute kidney injury
Pulmonary oedema
Neurological symptoms
Visual disturbance
Fetal growth restriction
Proteinuria threshold
≥300 mg per 24 hours
Or protein:creatinine ratio ≥30 mg/mmol
Key Point
Pre-eclampsia can be diagnosed without major proteinuria if maternal organ dysfunction is present.
3. Pathophysiology
Understanding mechanisms helps with clinical interpretation.
Chronic hypertension
Usually essential hypertension
Maternal vascular disease predates pregnancy
Pre-eclampsia
Abnormal placentation
Endothelial dysfunction
Vasospasm
Placental hypoperfusion
These mechanisms explain:
Proteinuria
Placental insufficiency
Fetal growth restriction
4. Maternal and Fetal Complications
Maternal complications of pre-eclampsia
Eclampsia
HELLP syndrome
Disseminated intravascular coagulation
Acute kidney injury
Pulmonary oedema
Intracranial haemorrhage
Fetal complications
Intrauterine growth restriction
Placental abruption
Prematurity
Intrauterine death
Candidates should remember that chronic hypertension increases the risk of superimposed pre-eclampsia.
5. Antihypertensive Drugs in Pregnancy
This is one of the highest-yield pharmacology areas in MRCP Part 1.
Preferred/Safe Drugs | Drugs to Avoid |
Labetalol | ACE inhibitors |
Nifedipine | ARBs |
Methyldopa | Sodium nitroprusside (routine use) |
Hydralazine | Mineralocorticoid antagonists |
Important Exam Fact
ACE inhibitors are contraindicated in pregnancy because of fetal renal toxicity.
Questions frequently ask:
Which drug should be stopped immediately?
Which antihypertensive is safest?
What is first-line treatment for severe hypertension in pregnancy?
High-Yield Comparison Table
Feature | Chronic Hypertension | Pre-eclampsia |
Onset | Before 20 weeks | After 20 weeks |
Proteinuria | Usually absent initially | Common |
Platelets | Normal | May be low |
Liver enzymes | Normal | May be elevated |
Placental disease | No | Yes |
Fetal growth restriction | Less common | Common |
Definitive treatment | Long-term BP control | Delivery |
10 High-Yield MRCP Part 1 Facts
Pre-eclampsia develops after 20 weeks.
Chronic hypertension predates pregnancy or appears before 20 weeks.
Severe hypertension in pregnancy is a medical emergency.
Proteinuria is not mandatory for diagnosis.
Labetalol is commonly first-line treatment.
ACE inhibitors are contraindicated.
HELLP syndrome is a severe form of pre-eclampsia.
Fetal growth restriction suggests placental insufficiency.
Delivery is the definitive treatment for pre-eclampsia.
Chronic hypertension predisposes to superimposed pre-eclampsia.
Mini-Case Example
A 30-year-old primigravida at 34 weeks presents with headache and blurred vision. Blood pressure is 170/110 mmHg. Urinalysis shows 3+ protein. Blood tests demonstrate platelets of 88 × 10⁹/L and elevated ALT.
What is the most likely diagnosis?
Answer: Severe pre-eclampsia with HELLP syndrome features.
Why?
This patient has:
Hypertension after 20 weeks
Significant proteinuria
Thrombocytopenia
Liver involvement
Neurological symptoms
These findings indicate severe disease requiring urgent management.
MRCP-Style SBA
Question
A 33-year-old woman at 11 weeks’ gestation is noted to have persistent blood pressure readings of 150/92 mmHg. Urinalysis is normal.
What is the most likely diagnosis?
A. Gestational hypertension B. Chronic hypertension C. Pre-eclampsia D. HELLP syndrome E. Eclampsia
Answer
B. Chronic hypertension
Explanation
Hypertension identified before 20 weeks strongly suggests pre-existing chronic hypertension rather than pre-eclampsia.
Practical Study-Tip Checklist
Before the exam, ensure you can:
Apply the “20-week rule” rapidly
Distinguish gestational hypertension from pre-eclampsia
Recognise severe-feature criteria
Identify HELLP syndrome
Recall safe antihypertensive drugs
Spot contraindicated medications instantly
Interpret proteinuria thresholds
Recognise fetal growth restriction patterns
Answer pregnancy pharmacology SBAs confidently
Interpret laboratory abnormalities quickly
Common Pitfalls
Confusing gestational hypertension with pre-eclampsia
Forgetting that proteinuria is not always required
Missing thrombocytopenia as a severe feature
Selecting ACE inhibitors in pregnancy questions
Ignoring gestational age in the clinical stem
FAQs
Is proteinuria essential for diagnosing pre-eclampsia?
No. Modern diagnostic criteria allow diagnosis without significant proteinuria if there is maternal organ dysfunction such as thrombocytopenia, renal impairment, or liver involvement.
Which antihypertensive is commonly first-line in pregnancy?
Labetalol is commonly used first-line. Nifedipine and methyldopa are also widely used and considered safe during pregnancy.
Why is pre-eclampsia dangerous?
Pre-eclampsia can progress to eclampsia, HELLP syndrome, pulmonary oedema, stroke, placental abruption, and fetal compromise.
What is the definitive treatment for pre-eclampsia?
Delivery of the placenta is the definitive treatment, although timing depends on maternal and fetal stability.
How is chronic hypertension distinguished from pre-eclampsia in MRCP questions?
The key clue is timing. Hypertension present before 20 weeks strongly suggests chronic hypertension.
Ready to start?
Strengthen your preparation with structured revision via the MRCP Part 1 overview. Practise actively using the Free MRCP MCQs and simulate exam conditions with a Start a mock test.
For deeper understanding, combine this guide with lecture-based revision at:https://www.crackmedicine.com/lectures/
Sources
MRCP(UK): <a href="https://www.mrcpuk.org/">https://www.mrcpuk.org/</a>
NICE Guideline — Hypertension in Pregnancy: <a href="https://www.nice.org.uk/guidance/ng133">https://www.nice.org.uk/guidance/ng133</a>
RCOG Green-top Guidelines: <a href="https://www.rcog.org.uk/guidance/">https://www.rcog.org.uk/guidance/</a>
British National Formulary: <a href="https://bnf.nice.org.uk/">https://bnf.nice.org.uk/</a>
Davidson’s Principles and Practice of Medicine
Oxford Handbook of Clinical Medicine
Comments